Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Income from Continuing Operations (2016 - 2026)

Nutex Health (NUTX) has disclosed Income from Continuing Operations for 17 consecutive years, with 62763000.0 as the latest value for Q1 2026.

  • For Q1 2026, Income from Continuing Operations rose 23.53% year-over-year to 62763000.0; the TTM value through Mar 2026 reached 192314000.0, up 31.09%, while the annual FY2025 figure was 180357000.0, 90.24% up from the prior year.
  • Income from Continuing Operations hit 62763000.0 in Q1 2026 for Nutex Health, up from 16608000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 100047254.0 in Q4 2024 and bottomed at 422909015.0 in Q3 2022.
  • Average Income from Continuing Operations over 5 years is 8099592.88, with a median of 542000.0 recorded in 2024.
  • Year-over-year, Income from Continuing Operations tumbled 667.71% in 2022 and then surged 9473.8% in 2025.
  • Nutex Health's Income from Continuing Operations stood at 10658584.0 in 2022, then crashed by 159.99% to 27711357.0 in 2023, then skyrocketed by 461.03% to 100047254.0 in 2024, then plummeted by 83.4% to 16608000.0 in 2025, then soared by 277.91% to 62763000.0 in 2026.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 62763000.0, 16608000.0, and 96799000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.